PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)
| Subclass | Title |
|---|---|
| 1/00 | General processes for the preparation of peptides |
| 1/02 | General processes for the preparation of peptides in solution |
| 1/04 | General processes for the preparation of peptides on carriers |
| 1/06 | General processes for the preparation of peptides using protecting groups or activating agents |
| 1/08 | General processes for the preparation of peptides using protecting groups or activating agents using activating agents |
| 1/10 | General processes for the preparation of peptides using coupling agents |
| 1/107 | General processes for the preparation of peptides by chemical modification of precursor peptides |
| 1/113 | General processes for the preparation of peptides by chemical modification of precursor peptides without change of the primary structure |
| 1/12 | General processes for the preparation of peptides by hydrolysis |
| 1/13 | General processes for the preparation of peptides Labelling of peptides |
| 1/14 | General processes for the preparation of peptides Extraction; Separation; Purification |
| 1/16 | General processes for the preparation of peptides Extraction; Separation; Purification by chromatography |
| 1/18 | General processes for the preparation of peptides Extraction; Separation; Purification by chromatography Ion-exchange chromatography |
| 1/20 | General processes for the preparation of peptides Extraction; Separation; Purification by chromatography Partition-, reverse-phase or hydrophobic interaction chromatography |
| 1/22 | General processes for the preparation of peptides Extraction; Separation; Purification by chromatography Affinity chromatography or related techniques based upon selective absorption processes |
| 1/24 | General processes for the preparation of peptides Extraction; Separation; Purification by electrochemical means |
| 1/26 | General processes for the preparation of peptides Extraction; Separation; Purification by electrochemical means Electrophoresis |
| 1/28 | General processes for the preparation of peptides Extraction; Separation; Purification by electrochemical means Electrophoresis Isoelectric focusing |
| 1/30 | General processes for the preparation of peptides Extraction; Separation; Purification by precipitation |
| 1/32 | General processes for the preparation of peptides Extraction; Separation; Purification by precipitation as complexes |
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0113,794 | METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE THE YIELD AND QUALITY OF CUCUMBER FRUITS | Jan 03, 24 | Apr 10, 25 | CH Biotech R&D Co., Ltd. |
| 2025/0113,846 | CORN PROTEIN CONCENTRATE AND METHODS OF MANUFACTURING SAME | Dec 19, 24 | Apr 10, 25 | Cargill Incorporated |
| 2025/0114,339 | COMBINATION THERAPY COMPRISING A KRAS G12D INHIBITOR AND AN EGFR INHIBITOR | Oct 08, 24 | Apr 10, 25 | Not available |
| 2025/0114,358 | ALS TREATMENT USING INDUCED REGULATORY T (ITREG) CELLS | Oct 11, 24 | Apr 10, 25 | RAPA THERAPEUTICS, LLC |
| 2025/0114,391 | BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT | May 17, 24 | Apr 10, 25 | HiberCell, Inc. |
| 2025/0114,392 | BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICRENVIRONMENT | May 20, 24 | Apr 10, 25 | HiberCell, Inc. |
| 2025/0114,400 | Application of SIRT1-7 protein in immunotherapy | Dec 30, 21 | Apr 10, 25 | Avenex Biosciences LTD. |
| 2025/0114,428 | DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES | May 03, 24 | Apr 10, 25 | Not available |
| 2025/0114,429 | VISTA ANTAGONIST AND METHODS OF USE | Jul 10, 24 | Apr 10, 25 | Not available |
| 2025/0114,432 | WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA | Dec 19, 24 | Apr 10, 25 | Not available |
| 2025/0114,433 | BINDING PROTEINS SPECIFIC FOR RAS NEOANTIGENS AND USES THEREOF | May 13, 24 | Apr 10, 25 | Not available |
| 2025/0114,443 | PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE | Aug 09, 24 | Apr 10, 25 | Children's Medical Center Corporation |
| 2025/0114,446 | LOW-SUGAR CORONAVIRUS VACCINE AND METHODS THEREOF | Oct 08, 24 | Apr 10, 25 | Not available |
| 2025/0114,449 | STABLE ANTI-OSMR ANTIBODY FORMULATION | May 23, 24 | Apr 10, 25 | Not available |
| 2025/0114,450 | PHARMACEUTICAL COMBINATION CONTAINING ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF | Mar 10, 22 | Apr 10, 25 | Not available |
| 2025/0114,451 | REDUCING POLYSORBATE DEGRADATION IN PROTEIN FORMULATIONS BY LOW AMOUNTS OF CITRIC ACID | Jan 17, 23 | Apr 10, 25 | Not available |
| 2025/0114,452 | LAT ACTIVATING CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF | Aug 04, 22 | Apr 10, 25 | Not available |
| 2025/0114,454 | MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF | Oct 30, 24 | Apr 10, 25 | Not available |
| 2025/0114,463 | LIVER-TARGETED DRUG AND USE THEREOF | Dec 22, 22 | Apr 10, 25 | HANMI PHARM. CO., LTD. |
| 2025/0114,467 | ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF | Jul 29, 22 | Apr 10, 25 | Not available |
| Upgrade to the Professional Level to view Top Owners for this Class.Learn More |
|---|
